Maze Therapeutics, Inc. - MAZE

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$1.628B

QoQ value delta ($000)

-$377.3M (-18.82%)

Implied price effect (QoQ)

-27.03%

Total shares

53,844,243

QoQ shares delta

+5,445,274 (+11.25%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 169 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Frazier Life Sciences Management, L.P.	136,333	4,567,274	3.51%
TRV GP IV, LLC	133,547	4,473,958	50.04%
ARCH Venture Management, LLC	122,983	4,120,053	18.16%
Deep Track Capital, LP	103,805	3,477,562	1.7%
JANUS HENDERSON GROUP PLC	85,280	2,858,876	0.04%
Paradigm Biocapital Advisors LP	81,920	2,744,399	1.67%
BlackRock, Inc.	76,727	2,570,425	0.0%
VANGUARD GROUP INC	70,307	1,697,015	0.0%
a16z Capital Management, L.L.C.	50,811	1,702,225	3.94%
Venrock Adviser, LLC	47,820	1,602,034	1.78%
VANGUARD CAPITAL MANAGEMENT LLC	42,854	1,435,656	0.0%
Alphabet Inc.	41,449	1,388,583	1.03%
Logos Global Management LP	36,864	1,235,000	1.84%
ADAGE CAPITAL PARTNERS GP, L.L.C.	35,163	1,178,000	0.05%
General Catalyst Group Management, LLC	30,921	1,035,910	16.84%
TRV GP V, LLC	28,381	950,800	7.08%
FMR LLC	25,796	864,214	0.0%
CITADEL ADVISORS LLC	24,155	809,214	0.0%
ArrowMark Colorado Holdings LLC	22,906	767,383	0.61%
Casdin Capital, LLC	22,651	758,857	1.72%
Cormorant Asset Management, LP	22,387	750,000	1.12%
Woodline Partners LP	19,409	650,229	0.07%
STATE STREET CORP	19,006	636,722	0.0%
DRIEHAUS CAPITAL MANAGEMENT LLC	18,989	636,162	0.14%
Caligan Partners LP	18,356	614,962	1.22%